Form 4: Natera CFO Sells Shares for Tax & Trading Plan

Natera's Chief Financial Officer, Michael Burkes Brophy, reported sales of common stock totaling 61,123 shares, primarily for tax obligations and under a pre-arranged trading plan.

Summary

• Michael Burkes Brophy, Natera's Chief Financial Officer, reported multiple transactions involving Natera, Inc. common stock.
• On January 20, 2026, Brophy acquired 1,522 shares through the vesting of Restricted Stock Units (RSUs) and sold 23,948 shares at $234.7384 to cover tax withholding obligations related to RSU vesting from a grant on January 27, 2023.
• On January 21, 2026, Brophy sold 602 shares at $235 to satisfy tax withholding obligations for another RSU vesting event from a grant on January 28, 2022.
• Additionally, on January 21, 2026, Brophy sold 36,573 shares at $242.6685 under a Rule 10b5-1 trading plan established on June 9, 2025, and modified on September 10, 2025.
• Following these transactions, Brophy's direct beneficial ownership of Natera common stock is 64,123 shares.

Sentiment

Score: 5

Explanation: The filing reports routine insider transactions, including sales for tax obligations and under a pre-arranged trading plan. These are generally neutral events, as they are expected parts of executive compensation and financial planning, rather than indicators of company performance or management's view on future prospects.

Positives

• The sales for tax withholding are a routine part of RSU compensation, indicating the vesting of equity awards.
• The sales under a Rule 10b5-1 plan demonstrate pre-planned transactions, reducing concerns about opportunistic insider selling.

Negatives

• The Chief Financial Officer sold a significant number of shares (61,123 shares in total across multiple transactions).

Future Outlook

NA

Industry Context

This filing reflects routine insider transactions for Natera's CFO, common across the biotechnology and diagnostics industry where executive compensation often includes equity awards that lead to periodic sales for tax purposes or personal financial planning via 10b5-1 plans. It does not provide specific insights into broader industry trends or competitive landscape.

Stakeholder Impact

• Shareholders: The sale of shares by a CFO, even if pre-planned or for tax, could be perceived negatively by some investors, though the 10b5-1 plan mitigates concerns of opportunistic selling. The overall impact is likely minimal given the routine nature.

Key Dates

Recommendation

The filing details routine insider transactions by Natera's CFO, primarily for tax obligations related to RSU vesting and under a pre-established 10b5-1 trading plan. These transactions are expected and do not typically signal a change in the company's fundamental outlook or management's confidence. Therefore, the filing itself does not provide a basis for a 'buy' or 'sell' recommendation, suggesting a 'hold' position as investors should rely on broader company performance and market analysis rather than these standard insider disclosures.

Keywords

Natera, NTRA, Form 4, Insider Trading, Stock Sale, CFO, Michael Burkes Brophy, Restricted Stock Units, RSU, 10b5-1 Plan, Equity Compensation